Skip to content

IEMbase 0619: SLC16A1-related monocarboxylate transporter-1 deficiency

Scope

Field Value
IEMbase ID 619
Nosology 4.3.04.01
Gene SLC16A1
External IDs OMIM:616095; ORPHA:438075
Generated mapping UNMAPPED
Candidate DisMech targets None exact; Primary_Carnitine_Deficiency.yaml is a weak false candidate
Review date 2026-07-07

IEMbase phenotype signal

IEMbase represents SLC16A1-related monocarboxylate transporter 1 deficiency / MCT1 deficiency as an autosomal dominant or autosomal recessive disorder with unknown treatability.

The biochemical signal is ketone-utilization focused: acetoacetate and ketones in blood/plasma and urine range from normal to very high in infancy and childhood, urinary 3-hydroxybutyric acid ranges from normal to very high, and urinary C6-C10 dicarboxylic acids range from normal to high. Glucose can be low to normal, while ammonia, lactate, free carnitine, acylcarnitines, and acylglycines are represented as normal in the cached rows.

Clinical and characteristic rows include optional developmental delay, optional hypoglycemia from the neonatal period through childhood, and optional ketoacidosis in infancy/childhood. The treatment row is avoidance of fasting with level 4 evidence from PMID:25390740, with decreased blood ketones as the reported metabolic effect.

DisMech phenotype coverage

No exact local SLC16A1/MCT1 deficiency entry was identified. Primary_Carnitine_Deficiency.yaml is a false candidate: SLC22A5-related carnitine transport deficiency is mechanistically and biochemically distinct from SLC16A1-related monocarboxylate/ketone transport deficiency.

This record should also stay distinct from the earlier SLC16A1 superactivity / HHF7 note. Both involve SLC16A1, but IEMbase separates MCT1 deficiency from exercise-induced hyperinsulinism due to MCT1 superactivity.

Concordance and completeness

Judgement: true local gap.

DisMech currently lacks an exact MCT1 deficiency target, and the closest local candidate is a transporter-neighborhood false positive rather than useful coverage.

Curation actions

  • Do not map to Primary_Carnitine_Deficiency.yaml.
  • Curate SLC16A1/MCT1 deficiency separately from SLC16A1/HHF7 superactivity.
  • Preserve ketone-utilization, hypoglycemia, ketoacidosis, normal carnitine/acylcarnitine, and avoidance-of-fasting prompts during source review.